View ICR - OIRA Conclusion



0910-0701 201412-0910-017
Historical Active 201107-0910-010
HHS/FDA CDER
Guidance for Industry on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic
Extension without change of a currently approved collection   No
Regular
Approved without change 04/06/2015
01/08/2015
  Inventory as of this Action Requested Previously Approved
04/30/2018 36 Months From Approved 04/30/2015
6,500 0 6,500
262,000 0 262,000
0 0 0